Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-16 · accession 0001783908-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | 2026-01-16 | JAZZ | Patil Neena M | EVP, CLO | A - Grant | $0.00 | +8,852 | 56.6K | +19% | $0 | |
| 2026-01-21 | 2026-01-16 | JAZZ | Patil Neena M | EVP, CLO | D - Sale to Iss | $171.16 | -3,275 | 53.3K | -6% | -$560.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-01-16 | A | A | 8,852 | $0.00 | 56,614 | D | — | — | (F2) The Reporting Person acquired 116 ordinary shares on May 30, 2025 and 120 ordinary shares on November 28, 2025 under a Section 423 Employee Stock Purchase Plan. |
| 2 | Common | Ordinary Shares | 2026-01-16 | D | D | 3,275 | $171.16 | 53,339 | D | — | — |